vasoactive agonist

• 血管作動薬、血管刺激薬

関

vasoconstrictor、vasoconstrictor agent、vasopressor agent、vasostimulant

WordNet

1. any agent that causes a narrowing of an opening of a blood vessel: cold or stress or nicotine or epinephrine or norepinephrine or angiotensin or vasopressin or certain drugs; maintains or increases blood pressure (同)vasoconstrictive, pressor
2. (biochemistry) a drug that can combine with a receptor on a cell to produce a physiological reaction
3. a muscle that contracts while another relaxes; "when bending the elbow the biceps are the agonist"
4. someone involved in a contest or battle (as in an agon)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 血管作動性腸管ポリペプチド vasoactive intestinal polypeptide
• 2. パーキンソン病の薬理学的治療 pharmacologic treatment of parkinson disease
• 3. 気道の神経制御 neuronal control of the airways
• 4. 低カリウム血症の原因 causes of hypokalemia
• 5. 食物アレルギーに対する今後の治療法 future therapies for food allergy

English Journal

• Histamine H3 receptor activation inhibits dopamine synthesis but not release or uptake in rat nucleus accumbens.

• Aquino-Miranda G1, Escamilla-Sánchez J1, González-Pantoja R1, Bueno-Nava A2, Arias-Montaño JA3.
• Neuropharmacology.Neuropharmacology.2016 Jul;106:91-101. doi: 10.1016/j.neuropharm.2015.07.006. Epub 2015 Jul 10.
• We studied the effect of activating histamine H3 receptors (H3Rs) on rat nucleus accumbens (rNAcc) dopaminergic transmission by analyzing [(3)H]-dopamine uptake by synaptosomes, and dopamine synthesis and depolarization-evoked [(3)H]-dopamine release in slices. The uptake of [(3)H]-dopamine by rNAcc
• PMID 26169221

• Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.

• Olson KE1, Bade AN1, Schutt CR1, Dong J2, Shandler SJ3, Boska MD1,2, Mosley RL1, Gendelman HE4, Liu Y1,2.
• Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.Neurotherapeutics.2016 Jun 21. [Epub ahead of print]
• Neuroprotective immunity is defined by transformation of T-cell polarity for therapeutic gain. For neurodegenerative disorders and specifically for Parkinson's disease (PD), granulocyte-macrophage colony stimulating factor or vasoactive intestinal peptide receptor 2 (VIPR2) agonists elicit robust an
• PMID 27329163

• Vasoactive intestinal peptide dampens formyl-peptide-induced ROS production and inflammation by targeting a MAPK-p47phox phosphorylation pathway in monocytes.

• Chedid P1,2,3, Boussetta T1,2,3, Dang PM1,2,3, Belambri SA1,2,3, Marzaioli V1,2,3, Fasseau M1, Walker F1,2,3,4, Couvineau A1,2,3, El-Benna J1,2,3, Marie JC1,2,3.
• Mucosal immunology.Mucosal Immunol.2016 Jun 8. doi: 10.1038/mi.2016.51. [Epub ahead of print]
• Reactive oxygen species (ROS) produced by the phagocyte NADPH oxidase (NOX2) are required for microbial clearance; however, when produced in excess they exacerbate inflammatory response and injure surrounding tissues. NOX2 is a multicomponent enzyme composed of membrane-associated cytochrome b588 an
• PMID 27271317

Japanese Journal

• New Molecular Mechanisms for Cardiovascular Disease : Contribution of Endothelium-Derived Hyperpolarizing Factor in the Regulation of Vasoconstriction in Peripheral Resistance Arteries

• Journal of pharmacological sciences 116(4), 332-336, 2011-08-20
• NAID 10029895441

• Characterization of the Inhibitory Effect of Vascular Endothelium on Agonist-Induced Vasoconstriction in Rat Mesenteric Resistance Arteries

• Journal of pharmacological sciences 108(1), 95-103, 2008-09-20
• NAID 10024322538

• P2Y2 Receptor-Mediated Ca2+ Signaling and Spontaneous Ca2+ Releases in Human Valvular Myofibroblasts

• International Heart Journal 49(2), 221-236, 2008
• NAID 130000069035

Related Links

• Structure-activity relationship of vasoactive intestinal peptide ...

... Tannu SA, Wasserman MA, Welton A, Bolin DR (1994) Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxis. J Pharmacol Exp Ther 270 ...

• Vasoactive Intestinal Peptide Inhaled Agonists: Potential Role ...

16 MATHIOUDAKIs A reducing their responsiveness to lipopolysaccharide. Mol Immu-nol. 2008; 45: 2970-2980. 31. Bolin DR, Michalewsky J, Wasserman MA, O’Donnell M. De-sign and development of a vasoactive intestinal peptide ...

---

★リンクテーブル★

リンク元	「vasopressor agent」「vasoconstrictor」「vasoconstrictor agent」「血管刺激薬」「血管作動薬」
関連記事	「vasoactive」

「vasopressor agent」

　　[★]

• 昇圧薬、血管収縮薬

関

hypertensor、pressor、vasoactive agonist、vasoconstrictor、vasoconstrictor agent

「vasoconstrictor」

　　[★]

• 血管収縮薬、血管収縮剤

関

vasoactive agonist、vasoconstrictor agent、vasopressor agent

　

「vasoconstrictor agent」

　　[★]

• 血管収縮薬

関

vasoactive agonist、vasoconstrictor、vasopressor agent

「血管刺激薬」

　　[★]

英

vasoactive agonist、vasostimulant

関

血管刺激性、血管作動薬

「血管作動薬」

　　[★]

英

vasoactive agonist

関

血管刺激薬、血管収縮薬、昇圧薬

「vasoactive」

　　[★]

• adj.

• 血管作動性の、血管作用性の